
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A molecular signature for the metabolic syndrome by urine metabolomics
Chiara Bruzzone, Rubén Gil‐Redondo, Marisa Seco, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 30
Chiara Bruzzone, Rubén Gil‐Redondo, Marisa Seco, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 30
Showing 1-25 of 30 citing articles:
New Advances in Metabolic Syndrome, from Prevention to Treatment: The Role of Diet and Food
Donatella Ambroselli, Fabrizio Masciulli, Enrico Romano, et al.
Nutrients (2023) Vol. 15, Iss. 3, pp. 640-640
Open Access | Times Cited: 105
Donatella Ambroselli, Fabrizio Masciulli, Enrico Romano, et al.
Nutrients (2023) Vol. 15, Iss. 3, pp. 640-640
Open Access | Times Cited: 105
Metabolomics as a powerful tool for diagnostic, pronostic and drug intervention analysis in COVID-19
Chiara Bruzzone, Ricardo Conde, Nieves Embade, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 30
Chiara Bruzzone, Ricardo Conde, Nieves Embade, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 30
Association between metabolic syndrome and uric acid: a systematic review and meta-analysis
Elena Raya-Cano, Manuel Vaquero Abellán, Rafael Molina‐Luque, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 31
Elena Raya-Cano, Manuel Vaquero Abellán, Rafael Molina‐Luque, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 31
Gut microbiota-derived metabolites: implications for metabolic syndrome and therapeutic interventions
Samuel Oluwadare Olalekan, Olalekan Olanrewaju Bakare, IO Osonuga, et al.
The Egyptian Journal of Internal Medicine (2024) Vol. 36, Iss. 1
Open Access | Times Cited: 5
Samuel Oluwadare Olalekan, Olalekan Olanrewaju Bakare, IO Osonuga, et al.
The Egyptian Journal of Internal Medicine (2024) Vol. 36, Iss. 1
Open Access | Times Cited: 5
The Association Between Periodontitis and the Prevalence and Prognosis of Metabolic Syndrome
Tao Li, Huadong Wu, Zhenzhen Fu, et al.
Journal of Multidisciplinary Healthcare (2025) Vol. Volume 18, pp. 1053-1065
Open Access
Tao Li, Huadong Wu, Zhenzhen Fu, et al.
Journal of Multidisciplinary Healthcare (2025) Vol. Volume 18, pp. 1053-1065
Open Access
Association between the atherogenic index of plasma and the systemic immuno-inflammatory index using NHANES data from 2005 to 2018
Jiayu Li, Dan Hou, Jiarong Li, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Jiayu Li, Dan Hou, Jiarong Li, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Valproate-Induced Metabolic Syndrome
N. А. Shnayder, V. V. Grechkina, Vera V. Trefilova, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1499-1499
Open Access | Times Cited: 10
N. А. Shnayder, V. V. Grechkina, Vera V. Trefilova, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1499-1499
Open Access | Times Cited: 10
Blood and Urinary Biomarkers of Antipsychotic-Induced Metabolic Syndrome
Aiperi K. Khasanova, В. С. Добродеева, N. А. Shnayder, et al.
Metabolites (2022) Vol. 12, Iss. 8, pp. 726-726
Open Access | Times Cited: 15
Aiperi K. Khasanova, В. С. Добродеева, N. А. Shnayder, et al.
Metabolites (2022) Vol. 12, Iss. 8, pp. 726-726
Open Access | Times Cited: 15
A metabolic readout of the urine metabolome of COVID-19 patients
Frutos C. Marhuenda‐Egea, Jennifer Narro-Serrano, M. J. Shalabi-Benavent, et al.
Metabolomics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 8
Frutos C. Marhuenda‐Egea, Jennifer Narro-Serrano, M. J. Shalabi-Benavent, et al.
Metabolomics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 8
Towards Multiplexed and Multimodal Biosensor Platforms in Real-Time Monitoring of Metabolic Disorders
Yong-Ho Chung, Hung Anh Nguyen, Jimmy Zhang, et al.
Sensors (2022) Vol. 22, Iss. 14, pp. 5200-5200
Open Access | Times Cited: 13
Yong-Ho Chung, Hung Anh Nguyen, Jimmy Zhang, et al.
Sensors (2022) Vol. 22, Iss. 14, pp. 5200-5200
Open Access | Times Cited: 13
Urine biomarkers discovery by metabolomics and machine learning for Parkinson's disease diagnoses
Xiaoxiao Wang, Xinran Hao, Jie Yan, et al.
Chinese Chemical Letters (2023) Vol. 34, Iss. 10, pp. 108230-108230
Open Access | Times Cited: 7
Xiaoxiao Wang, Xinran Hao, Jie Yan, et al.
Chinese Chemical Letters (2023) Vol. 34, Iss. 10, pp. 108230-108230
Open Access | Times Cited: 7
Insulin resistance in Alzheimer’s disease: The genetics and metabolomics links
Arwa M. Amin, Hamza Mostafa, Hani M. J. Khojah
Clinica Chimica Acta (2022) Vol. 539, pp. 215-236
Open Access | Times Cited: 12
Arwa M. Amin, Hamza Mostafa, Hani M. J. Khojah
Clinica Chimica Acta (2022) Vol. 539, pp. 215-236
Open Access | Times Cited: 12
The metabolomic profile associated with clustering of cardiovascular risk factors—A multi-sample evaluation
Lars Lind, Johan Sundström, Sölve Elmståhl, et al.
PLoS ONE (2022) Vol. 17, Iss. 9, pp. e0274701-e0274701
Open Access | Times Cited: 9
Lars Lind, Johan Sundström, Sölve Elmståhl, et al.
PLoS ONE (2022) Vol. 17, Iss. 9, pp. e0274701-e0274701
Open Access | Times Cited: 9
An NMR-Based Model to Investigate the Metabolic Phenoreversion of COVID-19 Patients throughout a Longitudinal Study
Rubén Gil‐Redondo, Ricardo Conde, Maider Bizkarguenaga, et al.
Metabolites (2022) Vol. 12, Iss. 12, pp. 1206-1206
Open Access | Times Cited: 9
Rubén Gil‐Redondo, Ricardo Conde, Maider Bizkarguenaga, et al.
Metabolites (2022) Vol. 12, Iss. 12, pp. 1206-1206
Open Access | Times Cited: 9
Individuals with Metabolic Syndrome Show Altered Fecal Lipidomic Profiles with No Signs of Intestinal Inflammation or Increased Intestinal Permeability
Mia J. Coleman, Luis M. Espino, Hernan Lebensohn, et al.
Metabolites (2022) Vol. 12, Iss. 5, pp. 431-431
Open Access | Times Cited: 8
Mia J. Coleman, Luis M. Espino, Hernan Lebensohn, et al.
Metabolites (2022) Vol. 12, Iss. 5, pp. 431-431
Open Access | Times Cited: 8
Using nuclear magnetic resonance urine metabolomics to develop a prediction model of early stages of renal disease in subjects with type 2 diabetes
J. Ricardo Lucio‐Gutiérrez, Paula Cordero-Pérez, Iris C. Farías-Navarro, et al.
Journal of Pharmaceutical and Biomedical Analysis (2022) Vol. 219, pp. 114885-114885
Closed Access | Times Cited: 8
J. Ricardo Lucio‐Gutiérrez, Paula Cordero-Pérez, Iris C. Farías-Navarro, et al.
Journal of Pharmaceutical and Biomedical Analysis (2022) Vol. 219, pp. 114885-114885
Closed Access | Times Cited: 8
Enhancing urinalysis with smartphone and AI: a comprehensive review of point-of-care urinalysis and nutritional advice
Haluk Çelik, Balım Bengisu Caf, Caner Geyik, et al.
Chemical Papers (2023) Vol. 78, Iss. 2, pp. 651-664
Closed Access | Times Cited: 4
Haluk Çelik, Balım Bengisu Caf, Caner Geyik, et al.
Chemical Papers (2023) Vol. 78, Iss. 2, pp. 651-664
Closed Access | Times Cited: 4
Serum Metabolomics and NF-κB Pathway Analysis Revealed the Antipyretic Mechanism of Ellagic Acid on LPS-Induced Fever in Rabbits
Fengfeng Xie, Li-Ba Xu, Hua Zhu, et al.
Metabolites (2024) Vol. 14, Iss. 8, pp. 407-407
Open Access | Times Cited: 1
Fengfeng Xie, Li-Ba Xu, Hua Zhu, et al.
Metabolites (2024) Vol. 14, Iss. 8, pp. 407-407
Open Access | Times Cited: 1
Metabolomics‐driven approaches for identifying therapeutic targets in drug discovery
Sophearith Pan, Lichang Yin, Jie Liu, et al.
MedComm (2024) Vol. 5, Iss. 11
Open Access | Times Cited: 1
Sophearith Pan, Lichang Yin, Jie Liu, et al.
MedComm (2024) Vol. 5, Iss. 11
Open Access | Times Cited: 1
NMR spectroscopy spotlighting immunogenicity induced by COVID-19 vaccination to mitigate future health concerns
Sher Ali, Štěpánka Nedvědová, Gul Badshah, et al.
Current Research in Immunology (2022) Vol. 3, pp. 199-214
Open Access | Times Cited: 5
Sher Ali, Štěpánka Nedvědová, Gul Badshah, et al.
Current Research in Immunology (2022) Vol. 3, pp. 199-214
Open Access | Times Cited: 5
Prospective Metabolomic Studies in Precision Medicine: The AKRIBEA Project
Maider Bizkarguenaga, Rubén Gil‐Redondo, Chiara Bruzzone, et al.
Handbook of experimental pharmacology (2022), pp. 275-297
Closed Access | Times Cited: 3
Maider Bizkarguenaga, Rubén Gil‐Redondo, Chiara Bruzzone, et al.
Handbook of experimental pharmacology (2022), pp. 275-297
Closed Access | Times Cited: 3
MetSCORE: a molecular metric to evaluate the risk of metabolic syndrome based on serum NMR metabolomics
Rubén Gil‐Redondo, Ricardo Conde, Chiara Bruzzone, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access
Rubén Gil‐Redondo, Ricardo Conde, Chiara Bruzzone, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access
Elevated circulating HHIP levels in patients with metabolic syndrome
Jinglin Lei, Yang Yu, Yerui Lai, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 736, pp. 150877-150877
Closed Access
Jinglin Lei, Yang Yu, Yerui Lai, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 736, pp. 150877-150877
Closed Access
Evaluation of Synthetic Data Generation Models for Balancing Multiclass Metabolomic Profiles
Saioa Elizondo, Mikel Hernandez, Francisco Londoño, et al.
(2024), pp. 56-61
Closed Access
Saioa Elizondo, Mikel Hernandez, Francisco Londoño, et al.
(2024), pp. 56-61
Closed Access
Urinary Metabolomic Profile of Youth at Risk of Chronic Kidney Disease in Nicaragua
Samantha Hall, Nathan H. Raines, Oriana Ramírez‐Rubio, et al.
Kidney360 (2023) Vol. 4, Iss. 7, pp. 899-908
Open Access | Times Cited: 1
Samantha Hall, Nathan H. Raines, Oriana Ramírez‐Rubio, et al.
Kidney360 (2023) Vol. 4, Iss. 7, pp. 899-908
Open Access | Times Cited: 1